Cholesterol Testing

World Market Report

MCP-3403

EXECUTIVE ENGAGEMENTS

POOL

499
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

102
Interactions with Platform & by Email

PARTICIPANTS

22
Unique # Participated

VALIDATIONS

8
Responses Validated*

COMPANIES

42
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

202

PAGES

273

EDITION

16

PRICE

USD 5450

CODE

MCP-3403


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Amid the COVID-19 crisis, the global market for Cholesterol Testing estimated at US$23 Billion in the year 2020, is projected to reach a revised size of US$35.8 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Diagnostic Centers, one of the segments analyzed in the report, is projected to record a 7.9% CAGR and reach US$13 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Physicians / Providers & Hospitals segment is readjusted to a revised 6.4% CAGR for the next 7-year period.
The Cholesterol Testing market in the U.S. is estimated at US$6.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.6 Billion by the year 2027 trailing a CAGR of 10.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
In the global Government Agencies segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.8 Billion in the year 2020 will reach a projected size of US$8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.9 Billion by the year 2027, while Latin America will expand at a 6.4% CAGR through the analysis period.

SELECT PLAYERS

Abbott Laboratories; AccuTech LLC; Akers Biosciences Inc.; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Boston Heart Diagnostics Corporation; Eurofins Scientific; F. Hoffmann-La Roche Ltd.; Home Access Health Corporation; Laboratory Corporation of America® Holdings; PTS Diagnostics; Quest Diagnostics Inc.; Randox Laboratories Ltd.; Sekisui Diagnostics LLC; Siemens Healthineers; Sigma-Aldrich Corp.

SEGMENTS

» End-Use (Diagnostic Centers, Physicians / Providers & Hospitals, Government Agencies)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Cholesterol Testing - An Overview
Recent Market Activity
Prevailing Scenario in the Global Healthcare Sector Favors Market Growth
Increasing Healthcare Expenditure
Wider Availability of Healthcare & Diagnostics Services
Growing Health-Consciousness
Lenience Towards Preventive Care
Cholesterol Testing – Global Key Competitors Percentage Market Share in 2022 (E)
Developed Regions Remain Key Revenue Contributors
Developing Economies Offer Significant Potential
Key Factors Driving Demand for Healthcare Services in Developing Regions
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (USA)
AccuTech, LLC (USA)
Akers Biosciences, Inc. (USA)
Beckman Coulter, Inc. (USA)
Bio-Rad Laboratories, Inc. (USA)
Eurofins Scientific (Luxembourg)
Boston Heart Diagnostics Corporation (USA)
F. Hoffmann-La Roche Ltd. (Switzerland)
Home Access Health Corporation (USA)
Laboratory Corporation of America® Holdings (USA)
PRIMA Lab SA (Switzerland)
PTS Diagnostics (USA)
Quest Diagnostics, Inc. (USA)
Randox Laboratories Ltd. (UK)
Sekisui Diagnostics, LLC (USA)
Siemens Healthineers (Germany)
Sigma-Aldrich Corp. (USA)
3. MARKET TRENDS & DRIVERS
Growing Prevalence of Cardiovascular Disease Steers Cholesterol Testing Volumes
Global Menace of Cardiovascular Disease: Quick Facts
A Brief Overview of Select Cholesterol-Driven Cardiac Disorders
Coronary Artery Disease
Hyperlipidaemia
CVD Statistics
Risk of CVD in Obese People Underpins Cholesterol Testing Volumes
Global Obesity Facts in a Nutshell
Cholesterol Screening Assumes Importance in Diabetes Care
Global Diabetes Expenditure: Opportunity Indicator
The Hypertension-Cholesterol Link Accelerates the Need for Cholesterol Screening
Aging Population - A Vital Demography
Uptrend in In-Vitro Diagnostics (IVD) Sector Signals Prospects
Healthy Growth in Cardiac IVD Market Augments Market Potential
Positive Momentum in Point of Care (POC) Diagnostics Generates Parallel Opportunities
POC Diagnostics - An Overview
POC Cholesterol Testing Makes Rapid Gains
Massive Demand for Lipid Panel/Lipid Profile Tests
Northbound Trajectory in POC LPT Services
Rise of C-reactive Protein Tests to Aid Market Growth
Cholesterol Testing: Evolution from Invasive to Non-Invasive
Recent Breakthroughs in Non-Invasive Cholesterol Testing Domain
Nonfasting Lipid Testing Invalidates the Need for Pre-Test Fasting
Cloud Screening Platforms Extend New Level of Convenience
Self-Testing Kits: An Emerging Issue for Full-Scale Services Providers
A Rapidly Evolving Market Enabled by Technology
Opportunities & Challenges in Self-Testing Industry
E-Retailing Drives Sales of Home Test Kits
A Brief Overview of Select Cholesterol Test Kits
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Physicians / Providers & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Government Agencies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Cholesterol Testing Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
UNITED STATES
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
JAPAN
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
CHINA
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
EUROPE
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
FRANCE
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
GERMANY
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
UNITED KINGDOM
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
AUSTRALIA
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Australia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
INDIA
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
India Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
LATIN AMERICA
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cholesterol Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
BRAZIL
Brazil Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
MEXICO
Mexico Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
MIDDLE EAST
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cholesterol Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
IRAN
Iran Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
ISRAEL
Israel Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027
AFRICA
Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com